aspirin and extended-release dipyridamole

Generic: aspirin and extended-release dipyridamole

Labeler: avkare
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name aspirin and extended-release dipyridamole
Generic Name aspirin and extended-release dipyridamole
Labeler avkare
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

aspirin 25 mg/1, dipyridamole 200 mg/1

Manufacturer
AvKARE

Identifiers & Regulatory

Product NDC 42291-116
Product ID 42291-116_485b7e08-a8d8-f491-e063-6294a90aa415
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206392
Listing Expiration 2027-12-31
Marketing Start 2017-04-27

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42291116
Hyphenated Format 42291-116

Supplemental Identifiers

RxCUI
259081
UPC
0342291116603
UNII
R16CO5Y76E 64ALC7F90C
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin and extended-release dipyridamole (source: ndc)
Generic Name aspirin and extended-release dipyridamole (source: ndc)
Application Number ANDA206392 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
  • 200 mg/1
source: ndc
Packaging
  • 60 CAPSULE in 1 BOTTLE (42291-116-60)
source: ndc

Packages (1)

42291-116-60 60 CAPSULE in 1 BOTTLE (42291-116-60)

Ingredients (2)

aspirin (25 mg/1) dipyridamole (200 mg/1)

Linked Drug Pages (1)

Aspirin and Extended-Release Dipyridamole ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "485b7e08-a8d8-f491-e063-6294a90aa415", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0342291116603"], "unii": ["R16CO5Y76E", "64ALC7F90C"], "rxcui": ["259081"], "spl_set_id": ["c9a73ec9-e468-46a5-b2c1-99f1f1536585"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["AvKARE"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (42291-116-60)", "package_ndc": "42291-116-60", "marketing_start_date": "20170427"}], "brand_name": "Aspirin and Extended-Release Dipyridamole", "product_id": "42291-116_485b7e08-a8d8-f491-e063-6294a90aa415", "dosage_form": "CAPSULE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "42291-116", "generic_name": "Aspirin and Extended-Release Dipyridamole", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Aspirin and Extended-Release Dipyridamole", "active_ingredients": [{"name": "ASPIRIN", "strength": "25 mg/1"}, {"name": "DIPYRIDAMOLE", "strength": "200 mg/1"}], "application_number": "ANDA206392", "marketing_category": "ANDA", "marketing_start_date": "20170427", "listing_expiration_date": "20271231"}